Effect of Different Timings of Protein Supplementation in Hemodialysis Patients
The Effect of Different Timings of Protein Supplementation on Variable Outcomes in Hemodialysis Patients
1 other identifier
interventional
120
1 country
1
Brief Summary
The aim of this work is to study the effect of different timings of protein supplementation on variable outcomes in hemodialysis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2023
CompletedFirst Posted
Study publicly available on registry
July 20, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedJuly 1, 2024
June 1, 2024
5 months
July 1, 2023
June 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
effect on nutritional status
assessment of nutritional status change at 6 weeks from baseline using Subjective Global Assessment (SGA)
6 weeks
effect on blood pressure
systolic and diastolic Blood pressure change at 6 weeks from baseline
6 weeks
effect on dialysis adequacy
Estimation of Kt/V change at 6 weeks from baseline
6 weeks
Secondary Outcomes (2)
effect on BMI
6 weeks
effect on serum albumin
6 weeks
Study Arms (3)
pre-dialytic
OTHER40 patients will receive oral protein nutritional supplement (ONS) (Fresubin protein powder 25mg/5scoops per hemodialysis session) for 8 weeks 1 hour before the start of the session (pre-dialytic).
intra-dialytic
OTHER40 patients will receive oral protein nutritional supplement (ONS) for 8 weeks 2 hours after the start of the session (intra-dialytic).
inter-dialytic
OTHER40 patients will receive oral protein nutritional supplement (ONS) for 8 weeks in non-dialysis days (inter-dialytic).
Interventions
oral protein nutritional supplement (ONS) (Fresubin protein powder 25mg/5scoops per hemodialysis session) given in group A (predialytic: 1 hour before the start of the session), in group B (intradialytic: 2 hours after the start of the session ), in group C (interdialytic: in non-dialysis days )
Eligibility Criteria
You may qualify if:
- Adult hemodialysis patients (≥18 years of age).
- Received dialysis for at least 6 months prior to study screening.
- Receive hemodialysis at least 3 times per week .
You may not qualify if:
- Receiving nutritional supplementation prior to study commencing or within 1 month of commencement in the study .
- Participants with an allergy to any ingredients in the nutritional supplements.
- Significant edema and fluid overload.
- Hepatic patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine, Aexandria University
Alexandria, 21526, Egypt
Related Publications (6)
Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 Nov;42(5):864-81. doi: 10.1016/j.ajkd.2003.07.016.
PMID: 14582032BACKGROUNDCarrero JJ, Nakashima A, Qureshi AR, Lindholm B, Heimburger O, Barany P, Stenvinkel P. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. Kidney Int. 2011 Apr;79(7):749-56. doi: 10.1038/ki.2010.487. Epub 2010 Dec 22.
PMID: 21178976BACKGROUNDIkizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C; International Society of Renal Nutrition and Metabolism. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013 Dec;84(6):1096-107. doi: 10.1038/ki.2013.147. Epub 2013 May 22.
PMID: 23698226BACKGROUNDAgarwal R, Georgianos P. Feeding during dialysis-risks and uncertainties. Nephrol Dial Transplant. 2018 Jun 1;33(6):917-922. doi: 10.1093/ndt/gfx195.
PMID: 28633456BACKGROUNDKistler BM, Benner D, Burrowes JD, Campbell KL, Fouque D, Garibotto G, Kopple JD, Kovesdy CP, Rhee CM, Steiber A, Stenvinkel P, Ter Wee P, Teta D, Wang AYM, Kalantar-Zadeh K. Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018 Jan;28(1):4-12. doi: 10.1053/j.jrn.2017.10.003.
PMID: 29249295BACKGROUNDElsayed MM, Elkazaz AM. The effect of different timings of protein supplementation on variable outcomes in hemodialysis patients: a randomized clinical trial. Clin Exp Nephrol. 2025 May;29(5):672-680. doi: 10.1007/s10157-025-02626-7. Epub 2025 Jan 18.
PMID: 39826005DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Mamdouh Elsayed, MD
lecturer
- STUDY CHAIR
Amr Mohamed El Kazaz, MBBCh
resident
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
July 1, 2023
First Posted
July 20, 2023
Study Start
November 1, 2023
Primary Completion
April 1, 2024
Study Completion
May 1, 2024
Last Updated
July 1, 2024
Record last verified: 2024-06